MARIA TERESA ELIZALDE: Open Payments
NPI 1538120373 · BOONSBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 9 payments from 8 companies in 2025. Trend: 2023 $161 · 2024 $88 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $40 |
| Exact Sciences Corporation | 1 | $29 |
| TMS NeuroHealth Centers Inc. | 1 | $29 |
| Amgen Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: Cologuard Collection Kit, TMS NeuroHealth Centers Inc., KRYSTEXXA, Ozempic, CAPLYTA, Rybelsus, ELIQUIS, VRAYLAR.
Industry payments across MD — which companies pay providers there.
